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Directed Differentiation of V3 Interneurons
from Mouse Embryonic Stem Cells
Hao Xu and Shelly E. Sakiyama-Elbert
Excitatory commissural V3 interneurons (INs) of the ventral spinal cord have been shown to balance locomotor
rhythm regularity and robustness in vivo. Unfortunately, due to the scarcity of these cells in the spinal cord, in
vitro studies of dissociated V3 INs have yet to be reported. In this study, we developed an induction protocol for
V3 INs from mouse embryonic stem cells. The effect of the concentration of a strong sonic hedgehog (Shh)
agonist (smoothened agonist [SAG]) and retinoic acid (RA) on expression of progenitor p3 and postmitotic V3
IN transcription factor markers (ie, Nkx2.2 and Sim1) was examined. Cells were differentiated toward a more
ventral fate by increasing the duration of SAG exposure from 4 days in a previously established motoneuron
induction protocol to 6 days. At the end of the induction period, transcription factor expression was assessed
using quantitative real-time polymerase chain reaction, immunocytochemistry, in situ hybridization, and flow
cytometry. Lower concentrations of RA and a longer duration of SAG exposure led to increased levels of p3 and
V3 marker expression. This novel induction protocol reveals the importance of Shh signaling duration in the
dorsal-ventral patterning of the neural tube, and it provides a method to obtain V3 INs for future studies to allow
better understanding their role in rewiring and regeneration after spinal cord injury.
Introduction
V3 interneurons (INs) are commissural glutamatergicneurons that have been shown to be involved in rhythm
generation networks within the spinal cord known as central
pattern generators (CPGs) [1–3]. They can be identified by
the p3 progenitor domain markers, Nkx2.2 and Ngn3, and the
postmitotic IN marker, Sim1 [4,5]. More recently Uncx has
been shown to be a mature V3 marker [6,7].
Initial fictive locomotor assays in Sim1 knockout mice
suggest that V3 INs have a role in balancing locomotor
outputs in the spinal cord to regulate left-right alternation in
gait [3]. More recent studies have demonstrated that spa-
tially separated and functionally distinct subpopulations of
V3 INs (termed V3ds and V3vs) can be differentially re-
cruited for running and/or swimming [2]. V3 INs also have
the ability to cross the midline and synapse onto motoneu-
rons (MNs) and other INs across multiple spinal segments
[5]. These findings suggest that V3 INs play a critical role
in locomotor coordination and may be involved in local
reorganization after spinal cord injury (SCI). An efficient
method to obtain V3 INs is necessary for enhanced under-
standing of CPGs and recovery after SCI.
Embryonic stem cells (ESCs) can provide a plentiful cell
source for cell replacement therapies and to study devel-
opmental biology. Protocols using retinoic acid (RA) and
sonic hedgehog (Shh) signaling to direct differentiation of
ESCs into various ventral spinal cell identities including
MNs [8] and V2a INs [9] by mimicking conditions found in
the developing ventral neural tube have been reported.
During development, RA released from laterally positioned
somites [10,11] and Shh released from the notochord and floor
plate (FP) generate overlapping gradients on the neural tube
[8,12–14]. Shh diffuses dorsally from the FP and notochord,
generating a ventral to dorsal signaling gradient (Fig. 1A). RA
is a caudalizing factor in neuronal differentiation [10,11,15,16]
(Fig. 1D) and may help pattern the dorsal-ventral identity of
embryoid body (EB)-derived neuronal populations in vitro
[11]. These two overlapping gradients specify different pro-
genitor domains (pMN and p0–p3) within the ventral cord,
which give rise to MNs and ventral IN classes (V0–V3), and
are identified by distinct transcription factors [5,13,17–21].
This complex interplay between Shh and RA serves as a basis
for specifying ventral neural differentiation from ESCs.
In this study, we establish a novel protocol to generate V3
INs from ESCs by assessing the effects of increasing Shh
signaling, prolonging the duration of Shh exposure, and
decreasing RA concentration on p3 progenitor and post-
mitotic V3 IN marker expression in ESC-derived neural
cultures. V2a INs, which lie dorsal to MNs, require a weaker
Shh signaling agonist than do MNs. Since V3 INs lie ventral
to both V2s and MNs [13,22], we hypothesized that further
increasing the Shh signaling level would promote increased
differentiation of V3 INs.
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Previous studies suggested that a more ventral spinal fate
is specified by increasing the duration of Shh exposure,
therefore we also chose to study the effects of varying the
duration of Shh exposure of cell fate (Fig. 1B) [19,20,22].
Furthermore, because the progenitor p3 domain lies further
from the RA-releasing somites than the pMNs, we hypoth-
esized that a lower RA concentration could further improve
V3 IN induction. Cells obtained with our protocol can be
used for studying CPG connectivity and cell-based trans-
plantation therapies.
Materials and Methods
Culture of ESCs
RW4 mouse ESCs (American Type Culture Collection,
Manassas, VA) were cultured on T-25 flasks coated in 0.1%
gelatin (Sigma, St. Louis, MO). Cells were cultured in
complete media consisting of Dulbecco’s modified Eagle
medium (DMEM 11965; Life Technologies, Carlsbad, CA)
containing 10% newborn calf serum, 10% fetal bovine se-
rum, and a 1:100 dilution of a 100· nucleosides mix (EMD
Millipore, Bellerica, MA). Cells were routinely passaged
every other day by washing with DMEM 11965 containing
25mM HEPES (Life Technologies) and dissociating with
1mL 0.25% trypsin ethylene diamine tetra acetic acid
(EDTA; Life Technologies), quenching with 4mL complete
media, and plating 1mL into a new T-25 gelatin-coated
flask containing a final volume of 5mL media with 1,000U/
mL leukemia inhibitory factor (EMD Millipore) and 100mM
b-mercaptoethanol (Life Technologies).
Formation and induction of EBs
RW4 ESCs were aggregated to form EBs on a nonadhe-
sive agar-coated surface and induced to generate neural
progenitors using our previously established 6-day induction
protocol (2-/4+) [8,16,23] or an 8-day induction protocol
(2-/6+). Cells were cultured in suspension for 2 days on
100mm petri dishes precoated with 0.1% agar (Thermo
Fisher Scientific, Waltham, MA) in DFK-5 media com-
prised of 1:1 DMEM/F12 (Life Technologies) with 5%
knockout serum replacement (Life Technologies), 1· insulin
transferrin selenium (Life Technologies), 100mM b-
mercaptoethanol, 50mM nonessential amino acids (Life
Technologies), and a 1:200 dilution of a 100· nucleosides mix.
During the first 2 days, the cells are not exposed to RA or
smoothened agonist (SAG) (hence 2-), allowing the cells to
aggregate into multicellular EBs. After the first 2 days of
aggregation, EBs were plated on gelatin. Two hundred mi-
croliters of EBs were removed from the 100mm plate and
replated onto one well of a gelatinized six-well plate. DFK-5
media was added to a final volume of 2mL and supple-
mented with RA (0–10 mM; Sigma) and SAG (EMD Milli-
pore) (0–1.25mM) on day 3 through the end of the induction
(either 4 days or 6 more days for 4+ or 6+, respectively).
Media with RA and SAG was replaced every 2 days for
4 (2-/4+) or 6 (2-/6+) days (Fig. 2A).
Quantitative real-time polymerase chain reaction
Following induction, each well of a six-well plate was
lysed with 750mL of buffer RLT from the RNeasy Mini Kit
FIG. 1. (A) Diagram depicting the ventral developing neural tube. The gradient of sonic hedgehog (Shh) arising from the
floor plate establishes the ventral progenitor domains (p1–p3 and pMN). Specific transcription factors expressed in these
domains drive the maturation of the committed domains (V1–V3 and motoneuron), which are defined by specific tran-
scription factors (shown on the far right). Adapted from Brown et al. and Dessaud [9,19]. (B) A schematic depicting the
effect of time and concentration on establishing progenitor domains. With increasing duration of high Shh exposure, more
ventral domains are established. Adapted from Dessaud et al. [19]. (C) Schematic depicting the distance from retinoic acid
(RA)-expressing somites. (D) Illustration of the rostral-caudal axis and direction of increasing RA expression.
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(Qiagen, Valencia, CA). RNA was extracted per the man-
ufacturer’s instructions. High Capacity RNA-to-cDNA Kit
(Life Technologies) generated cDNA from extracted RNA.
TaqMan Gene Expression Assays (Life Technologies;
Table 1) and TaqMan Fast Advanced Master Mix (Life
Technologies) were subsequently combined with the puri-
fied cDNA for quantitative real-time polymerase chain re-
action (qRT-PCR). Reactions were then performed using a
Step One Plus Applied Biosystems thermocycler with the
default protocol: 95C for 20 s, 40 cycles of 95C for 1 s,
and 60C for 20 s.
Ct values, the number of cycles necessary for the fluo-
rescent intensity to increase exponentially, were recorded
and normalized to b-actin expression. The comparative
DCt method [24] was used to analyze the mRNA expres-
sion levels in cultures postinduction (2-/4+ and 2-/6+). Fold
differences in relative mRNA expression levels over the
control cultures are reported for each gene (n ‡ 3 for all
groups).
Live/Dead viability assay
Live/Dead reagent (Life Technologies) consisting of
calcien-AM and ethidium homodimer was used to visualize
live and dead cells, respectively. Cells were dissociated and
incubated in Live/Dead reagents as per manufacturer in-
structions for flow cytometry. For each culture, 30,000
events were recorded using a BD LSRII flow cytometer
FIG. 2. Effect of smoothened agonist (SAG) concentration and duration of exposure on gene expression. (A) Schematic
depicting the 2-/6+ induction protocol where embryonic stem cells are aggregated in agar-coated plates for 2 days and then
exposed to 6 days of RA and Shh signaling. (B, D, E) Quantitative real-time polymerase chain reaction results (n= 3) at the
end of a 2-/4+ and 2-/6+ induction for mRNA levels compared to the uninduced (no RA, no SAG) control. (B) Sim1 gene
expression after induction. All 2-/6+ groups express significantly more Sim1 than their 2-/4+ counterparts. 0.5 mM SAG at
2-/6+ was significantly >1 and 1.25mM groups. *P< 0.05 versus the same SAG concentration with the 2-/4+ induction;
#P< 0.05 versus 1 mM SAG group at the same time point. (C) The effect of SAG concentration on cell death. #P < 0.05
versus 1mM SAG; ¤P< 0.05 versus 1.25 mM SAG. (D) Nkx2.2 gene expression after induction. At 0.5 mM SAG, Nkx2.2
expression at 2-/6+ was significantly greater than at 0.75, 1, and 1.25 mM. ^P< 0.05 versus 0.75, 1, and 1.25mM at the same
time point (2-/6+). (E) Hb9 expression after induction. No significance was observed across SAG concentration groups for
Hb9 at either time points. *P < 0.05 versus 2-/4+ induction groups at the same SAG concentration.
Table 1. Taqman Probes for qRT-PCR
Marker Life Tech identification
Beta-actin Mm00607939_S1
Sim1 Mm00441390_m1
Nkx2.2 Mm00839794_m1
HB9 Mm00658300_G1
RAX Mm01258704_m1
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(Becton Dickinson, Franklin Lakes, NJ). Data analysis was
performed using FloJo software (FloJo, Ashland, OR).
Dissociation and plating of EBs
Standard tissue culture plates were precoated with 0.01%
poly(ornithine) solution (Sigma) at 37C for 1 h. Poly(-
ornithine) was removed and plates were washed thrice with
a HEPES-buffered saline solution. Plates were then coated
with 0.01mg/mL laminin (Life Technologies) in HEPES-
buffered saline solution overnight and washed thrice be-
fore use as laminin-coated plates. Induced 2-/6+ EBs were
allowed to settle and supernatant was collected. Then,
0.25% Trypsin-EDTA was used to dissociate the EBs.
Dissociated cells were plated at a density of 100,000 cells/
cm2 in the collected DFK-5 supernatant.
Immunocytochemistry
For plated cultures, cells were fixed by adding 4% para-
formaldehyde (PFA) in phosphate-buffered saline (PBS) to
the cultures for 20min at room temperature, permeabilized
with 0.01% Triton X-100 (Sigma) for 20min. Cells were
then blocked with 5% normal goat serum (Sigma) in PBS
for 1 h and stained overnight in 2% normal goat serum in
PBS with added primary antibody (mouse anti-Nkx2.2,
1:100, Developmental Studies Hybridoma Bank, Iowa City,
IA; mouse anti-Ngn3, 1:100, Developmental Studies Hy-
bridoma bank; mouse anti-Uncx, 1:500, EMD Millipore)
overnight at 4C. Cells were then stained for 1 h in 2%
normal goat serum in PBS with Alexa Fluor-conjugated
antibodies (goat anti-mouse IgG 488; Life Technologies) at
4C, then Hoechst 33258 (1:1,000; Life Technologies) for
15min at room temperature, and stored in PBS at 4C.
Probe synthesis for in situ hybridization
Plasmids for in situ hybridization probes were a generous
gift from Dr. Paul Gray (Washington University) [25]. Gene
fragments from verified plasmids were linearized by direct
PCR amplification using ReadyMade Primers (SP6 Pro-
moter and T7 Promoter; Integrated DNA Technologies,
Coralville, IA). Digoxigenin (DIG)-labeled antisense and
sense RNA probes were made using PCR products as tem-
plate and T7 RNA polymerases (Roche, Indianapolis, IN).
Probes were used at a concentration of 1–2 mg/mL. Sense
counterparts of all probes were tested to ensure probe
specificity.
In situ hybridization
Cell cultures were fixed and stained with modifications
protocol from previously described [25–27]. Cell cultures
were fixed in 4% PFA for 10min and washed thrice in
diethylpyrocarbonate (DEPC; Sigma)-treated PBS at room
temperature. Next, cells were treated with RIPA buffer
[150mM NaCl (Thermo Fisher Scientific), 1% NP-40
(Thermo Fisher Scientific), 0.5% Na deoxycholate (Thermo
Fisher Scientific), 0.1% sodium dodecyl sulfate (Sigma),
1mM EDTA (Thermo Fisher Scientific), 50mM Tris in
DEPC (Sigma)-treated water at pH 8.0], and washed twice
with DEPC-treated PBS. Then, the cells were incubated in
0.1M triethanolamine-HCl [1.3% triethanol amine (Sigma)
and 0.4% HCl (Thermo Fisher Scientific)] with 0.25% acetic
anhydride (Sigma) for 10min. Cells were washed in 1·
saline sodium citrate (SSC) buffer for 5 min at room
temperature.
Three additional washes with DEPC-treated PBS were
performed before cells were blocked in hybridization buffer
[50% formaldehyde (Sigma), 5· SSC buffer (Life Tech-
nologies), 0.3mg/mL yeast RNA (Sigma), 0.1mg/mL hep-
arin (Sigma), 1· Denhardt’s solution (Life Technologies),
0.1% tween (Sigma), and 5mM EDTA] for 4–6 h at room
temperature. Cells were incubated in hybridization buffer
containing 1–2mg/mL DIG-labeled antisense cRNA over-
night at 65C. Probed cells were washed twice in 0.2· SSC
at 62C, and incubated in 0.2· SSC for 60min at 65C.
Washed cells were adjusted to room temperature and
blocked with 10% deactivated horse serum (Life Technol-
ogies) in PBS with 2mg/mL bovine serum albumin and
0.1% Triton X-100 (PBT), and incubated in alkaline
phosphatase-labeled anti-DIG antibody (1:2,000 in 10%
deactivated horse serum in PBT; Roche) overnight. Cells
were further washed with PBT and color was visualized
using nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl
phosphate (Roche). Staining was stopped with 4% PFA after
visual inspection. Cell nuclei were stained with the DNA
binding dye Hoechst (1:1,000, Life Technologies) and by
immunocytochemistry with Nkx2.2.
Flow cytometry
Immediately following the induction protocol, EBs were
stained for flow cytometry. Cultures were dissociated with
0.25% trypsin-EDTA for 20min at 37C. An excess volume
of complete media was added to quench the trypsin-EDTA,
and cultures were triturated to obtain single cell suspen-
sions. The cells were centrifuged at 360g for 6min, the
media was removed, and the cells were fixed, permeabi-
lized, and stained according to the Transcription Factor
Buffer Set (562725; BD Pharmingen, Franklin Lakes,
NJ) manufacturer’s instructions with mouse anti-Nkx2.2
(1:100), mouse anti-Isl1 (1:100; Developmental Studies
Hybridoma Bank), and mouse anti-Hb9 (1:20; Develop-
mental Studies Hybridoma Bank) primary antibodies and
appropriate Alexa Fluor secondary antibodies (1:200; Life
Technologies).
Following the induction protocol, nuclei were stained
with Hoechst (0.5mg/mL; Life Technologies) for 15min.
For each culture, 10,000 events were recorded using a Canto
II flow cytometer (Becton Dickinson). Data analysis was
performed using FloJo software (FloJo). Debris was re-
moved by gating using the forward scatter versus side
scatter and Hoechst fluorescence versus forward scatter
plots. Control groups of cells stained with only secondary
antibodies were used to determine gating parameters. Re-
sults of the flow cytometry are presented as percentage
primary antibody+ cells out of the total Hoechst+ population.
Sample gating is presented along side flow cytometry data.
Statistics
For quantitative experiments, at least three replicates of
each condition were analyzed. For cell counting, at least
three images were analyzed of every replicate to provide a
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representative sample of the replicate. Statistica soft-
ware (version 5.5, StatSoft, Inc., Tulsa, OK) was used for
statistical analysis. Significance was determined using
Scheffe’s post hoc test for analysis of variance with 95%
confidence. Average values are reported with error bars
indicating the standard error of the mean.
Results
Effect of SAG concentration and duration
of exposure on gene expression
The effect of increasing the concentration and duration of
exposure of SAG on gene expression was examined using
qRT-PCR to evaluate expression of V3 and pMN ventral
neural markers (Sim1, Nkx2.2, and Hb9). Concentrations of
SAG were varied from 0.5 to 1.25 mM with 2 mM RA
present, and samples were collected after 2-/4+ and 2-/6+
inductions. In this notation, ‘‘2-’’ refers to the number of
days ES cells are allowed to aggregate into EBs without (-)
RA and SAG (middle section of Fig. 2A). The ‘‘4+’’ or ‘‘6+’’
refers to the number of days the EBs are exposed to (+) RA
and SAG (right section of Fig. 2A).
mRNA expression fold change was determined by com-
paring qRT-PCR Ct values of induced cells to uninduced
cells that were not exposed to RA or SAG over the same
culture period (n ‡ 3 for all conditions). Expression of the
postmitotic V3 marker, Sim1, increased across all concen-
trations of SAG when the SAG exposure time increased
from 4 to 6 days (2-/4+ to a 2-/6+ induction) (Fig. 2B). After
the 2-/6+ induction, the group treated with 0.5 mM SAG
exhibited significantly higher levels of Sim1 expression than
the group treated with 1 mM SAG (22.5 – 0.5-fold greater
versus 15.0 – 1.3-fold greater than uninduced control).
Further reduction of the SAG concentration to as low
as 0.05 mM did not alter Sim1 expression significantly.
Additionally, after the 2-/6+ induction, the group treated
with 0.5 mM SAG exhibited significantly higher levels of
Nkx2.2mRNA (30.5– 4.4-fold greater than uninduced con-
trol) compared to other SAG concentrations tested (Fig. 2C).
Furthermore, Hb9 expression did not significantly change
with SAG concentration at a given time point, but it was
lower for the 2-/6+ induction compared to the 2-/4+ induction
in most groups (Fig. 2D). Hb9 and Nkx2.2 expression levels
showed similar trends to the Sim1 results, indicating that
prolonged exposure promotes the targeted gene expression
for V3 INs. We observed, at higher SAG concentrations,
more EBs detached in cultures on gelatin-coated plates.
To understand why we were observing a decrease in Sim1
induction efficiency, we assessed the percentage of cells
surviving after the 2-/6+ induction with 0.5, 0.75, 1.0, and
1.25 mM SAG. We found that there was a significant in-
crease in cell death at 1.25 and 1.0 mM SAG (Fig. 2C).
Therefore, 0.5 mM SAG and the 2-/6+ induction protocol
were used for subsequent studies.
Effect of RA concentration on gene expression
To investigate the effect of RA concentration on ventral
neural identity, qRT-PCR was used to evaluate changes in
FIG. 3. The effect of RA concentration on ventral neural marker gene expression. (A) Sim 1 and Nkx2.2 expression after
induction compared to 0.5 mM SAG and 2mM RA. *P< 0.05 versus 0.1 and 10 mM RA groups. Dotted line denotes
upregulation threshold compared to 0.5 mM SAG and 2 mM RA. (B) Hb9 expression after induction compared to 0.5 mM
SAG and 2 mM RA. ***P < 0.001 versus all other groups; **P < 0.01 versus 0.0005 and 0.001mM RA groups; #P < 0.05
versus 0.0005 mM RA group. Dashed line denotes downregulation threshold compared to 0.5 mM SAG and 2 mM RA. (C)
RAX expression after 2-/6+ induction compared to 0 mM SAG and 0 nM RA. ^P < 0.05 versus 0 nM RA group. Dashed line
denotes downregulation threshold compared to uninduced control.
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Sim1, Nkx2.2, and Hb9 expression. The concentration of
RA was varied from 0.005 to 10 mM in combination with
SAG (at a constant level of 0.5 mM), and samples were
collected at the end of the 2-/6+ induction protocol. Gene
expression levels were compared to baseline concentration
for the motor neuron induction protocol (2 mM RA), mRNA
expression fold change was established by comparing qRT-
PCR Ct values of all induced groups to the group treated
with 2mM RA and 0.5 mM SAG (n‡ 3 for all conditions,
highest Nkx2.2 and Sim1 levels in Fig. 2).
When RA concentration decreased to 0.01 mM, Sim1
expression was found to increase 11.4 – 2.9-fold versus the
2 mM RA group (Fig. 3A). Similarly, decreasing RA con-
centration to 0.01 mM significantly increased Nkx2.2mRNA
levels (4.3 – 0.4-fold) versus the 2 mM RA group. Hb9 ex-
pression levels decreased significantly when the RA con-
centration was lowered for all concentrations tested
compared with the 2mM RA group (Fig. 3B). Further low-
ering of RA concentration beyond 0.01 mM did not signifi-
cantly change Sim1 or Nkx2.2 expression levels. The
increase in Sim1 and Nkx2.2 combined with the decrease in
Hb9 matched gene expression patterns expected for V3 INs,
indicating lowering the concentration of RA did induce
further ventralization of our culture.
To test for unwanted rostralization with lower RA levels,
gene expression levels of retina and anterior neural fold
homeobox (RAX, a hypothalamus marker) were examined
using qRT-PCR. We tested the effect of varying the RA
concentration from 0 to 10 mM with 0.5 mM SAG using a
2-/6+ induction protocol. All data were compared to the
uninduced condition at the same time point to investigate
the extent of rostralization for each RA concentration.
All conditions showed decreased RAX expression com-
pared with uninduced controls (Fig. 3C, dashed line). Ad-
ditionally, RAX expression was significantly lower for
groups at 0.01 and 0.1 mM RA compared with the groups at
0 mM RA and 0.5 mM SAG. The downregulation of RAX
suggests that Sim1 expression was not an indicator of hy-
pothalamus induction in these cultures.
Immunocytochemistry and flow cytometry
To confirm the results observed by qRT-PCR, immuno-
cytochemistry and flow cytometry were used to assess
transcription factor expression at the protein level. Nkx2.2
immuno-cytochemistry on intact EBs (Fig. 4A–I) qualita-
tively suggested an increase in Nkx2.2mRNA levels with
decreasing RA. To quantify this difference, immunocyto-
chemistry was performed on dissociated EBs to see whether
p3 and V3 marker expression was increased in induced
cultures. Total cell nuclei and nuclei positive for the markers
were counted and the percentage of cells positive for the
following markers: Nkx2.2, Ngn3, and Uncx was calculated.
For all three markers, the percentage of cells positive for the
FIG. 4. The effect of decreasing RA
concentration on Nkx2.2 expression
by immunocytochemistry. Embryoid
bodies (EBs) fixed at the end of 2-/6+
induction with 0.5 mM SAG and
2 mM RA (A–C), 0.1 mM RA (D–F),
0.01 mM RA (G–I). Hoechst nuclear
staining (A, D, G), Nkx2.2 antibody
staining (B, E, H), and overlay of the
two stains (C, F, I) are shown. (J)
Quantification of p3 (Nkx2.2 and
Ngn3) and V3 (Uncx) marker immu-
nocytochemistry on dissociated EBs
plated onto laminin-coated plates.
Values given as percentage cells pos-
itive for marker. *Significance (P<
0.05) compared to 2 mM RA; ^signifi-
cance (P < 0.05) compared to 0.1 and
2 mM RA. Scale bar= 50mm. Color
images available online at www
.liebertpub.com/scd
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given marker increased when RA concentration was de-
creased from 2.0 to 0.01 mM RA.
Nkx2.2+ cells increased from 9% to 18%, Uncx+ cells
increased from 1% to 8%, and Ngn3+ cells increased from
7% to 13% (Fig. 4J). Similarly, flow cytometry showed the
percentage of Nkx2.2+ cells increased with decreasing RA
concentration down to 0.01 mM RA (Fig. 5). Groups induced
with 0.01 mM RA (and 0.5 mM SAG) using the 2-/6+ in-
duction protocol generated significantly more Nkx2.2+ cells
than those induced with 2 mM RA (and 0.5 mM SAG) (Fig.
5C). The percentage of cells positive for MN marker Isl1
also significantly decreased at 0.01mM RA compared with
2 mM RA (Fig. 5D). The percentage of Hb9+ cells signifi-
cantly decreased at both 0.01 and 0.1 mM RA compared with
2 mM RA, similar to the low Hb9mRNA levels seen in Fig.
3B. The decrease in MN marker expression and increase in
p3 marker expression corroborated that lowering RA further
ventralized the induced neural population.
In situ hybridization of Sim1 on EBs
Due to the lack of a specific Sim1 antibody, in situ hy-
bridization was used to confirm the presence of Sim1+ cells.
EBs were dissociated after 2-/6+ induction (varying RA
from 0.01 to 2 mM and constant 0.5 mM SAG). Performing in
situ hybridization for Sim1 showed that lowering the RA
concentration resulted in an increase in Sim1+ cells. At
0.01 mM RA, more Sim1+ cells were observed than at 0.1
and 2mM RA (Fig. 6M). When dissociated EBs were stained
with Nkx2.2 antibody after in situ hybridization, Nkx2.2 and
Sim1 expression was observed to colocalize (Fig. 6I–L,
arrowheads). This observation suggested that the induced
cells are spinal V3 INs.
Discussion
Commissural glutamatergic V3 INs have been shown to
be involved in rhythm regulation in the CPGs [1,28] by
helping regulate left-right walking gait and generating ro-
bust rhythmic bursting [2,3]. Their role in regulating CPGs
makes V3 INs an interesting target for understanding the
development of the locomotor pathway and local rewiring
after SCI. However, a readily available cell source for iso-
lation of V3 INs in culture would allow greater under-
standing of their role at a cellular level. In this article we
present data on establishing a novel induction protocol for
generating V3 INs from mouse ESCs.
Using a previously established 2-/4+ protocol for the in-
duction of MNs from mouse ESCs as a starting point, we
explored the effects of varying level and duration of expo-
sure to Shh signaling on p3 and V3 marker expression [8].
Although we hypothesized that increasing both the magni-
tude and duration of Shh exposure would drive more ventral
neural identities, qRT-PCR data indicated that increasing
FIG. 5. The effects of RA
concentration on neuronal
marker expression by flow
cytometry. Flow cytometry
performed on induced EBs
after the 2-/6+ induction with
0.5 mM SAG and varying RA
concentrations (0.01, 0.1, and
2 mM). (A) Sample gating of
flow cytometry for 2 mM RA
and 10 nM RA for negative
control (secondary antibody
only, -ctrl), Nkx2.2, Hb9,
and Isl1 stains. Region on left
is negative while region on
right is positive. (B) Quanti-
fication of percentage cells
staining positive for Nkx2.2,
Hb9, and Isl1 across various
RA concentrations. *Sig-
nificance (P < 0.05) versus
compared to 2 mM RA
groups.
DIFFERENTIATION OF V3 INTERNEURONS FROM MOUSE ESCS 2729
the duration rather than the concentration of Shh signaling
agonist appeared to be more effective for induction of V3
INs. While the expectation that lower Shh exposure will
result in more dorsal cell types has proven true for V2a and
V0 differentiation, it has been observed in our lab that
higher concentrations of SAG do not improve MN induction
and appear to have a negative effect on EB health. The
decreased efficacy of SAG at concentrations higher than
1 mM has been reported at early time points (30 h) [29].
Gli, a downstream target of SAG, was coupled to a lu-
ciferase assay and luciferase activity was reported to peak
between 0.1 and 1 mM SAG, indicating peak SAG-driven
Gli activation occurs somewhere between these values [29].
We surmised the observed decrease in Sim1 expression in
our studies at concentrations of 1 mM or greater could be due
to toxic effects of high SAG levels. This was confirmed with
live–dead quantification of our induced cultures (Fig. 2C).
Since SAG efficacy was limited at higher concentrations, an
increase in Sim1 expression levels was only observed with
increasing SAG exposure time and not concentration.
Because V3 INs are further than MNs from RA-releasing
somites along the neural tube [10], we hypothesized that
lowering the RA concentration would increase V3 IN dif-
ferentiation. Our qRT-PCR data showed that decreasing RA
concentration not only increased Nkx2.2 and Sim1 gene
expression but also decreased Hb9 expression, indicated that
lowering RA allows differentiation of more ventral popu-
lations. These data were further supported by flow cytom-
etry and immunocytochemistry for Nkx2.2 and Isl1, and in
situ hybridization for Sim1. Others have also shown that
lowering RA to the 0.001–0.01mM range increases Nkx2.2
expression [11], which matches with our observations.
While we observed increases in Sim1 expression by qRT-
PCR, validation of the induction protocol required the
presence of cells with high levels of Sim1 expression. Since
a specific Sim1 antibody is not available we used in situ
hybridization to confirm that the increase in overall Sim1
expression, as seen in qRT-PCR, can be attributed to some
cells with high levels of Sim1 expression and not low levels
of Sim1 expression in most cells. When dissociated EBs
FIG. 6. Sim1 and Nkx2.2
in dissociated EBs indicated
by in situ hybridization and
immunocytochemistry. Cul-
tures induced with the 2-/6+
protocol with 0.5mM SAG
and 2mM RA (A–D),
0.1mM RA (E–H), 0.01mM
RA (I–L) were dissociated
and plated and then stained
by in situ hybridization for
Sim1 and immunocyto-
chemistry for Nkx2.2. Sim1
in situ hybridization (A, E,
I), Nkx2.2 antibody staining
(B, F, J), Hoechst nuclear
staining (C, G, K) and
overlay of all three stains
with Nkx2.2 false colored as
red and Hoechst false col-
ored as green (D, H, L) are
shown. Arrowheads mark
Sim1+ cells. (M) Quantifi-
cation of scale bar = 50 mm.
Color images available
online at www.liebertpub
.com/scd
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were stained with Nkx2.2 antibody after in situ hybridiza-
tion, Nkx2.2 and Sim1 expression was observed to coloca-
lize (Fig. 6I–L, arrowheads). This observation suggested
that the induced cells are spinal V3 INs.
Because Sim1 is not uniquely expressed in V3 INs, it was
necessary to ensure that the induction protocol did not give
rise to other Sim1+ neural populations. One concern with
decreasing RA concentration is potential rostralization of
the resulting cells. Since Sim1 is also expressed in the hy-
pothalamus [30], we wanted to ensure the cells we obtained
were not hypothalamus cells. To this end, the level of gene
expression of the hypothalamus marker RAX was measured
in the Sim1+ cultures generated in the low RA, high SAG
induction protocol. Due to the heterogeneity of induction
protocols [8,11,15], if the induced Sim1+ EBs upregulate
RAX they could have hypothalamic identity [31–33]. The
drastic downregulation of RAX after induction (Fig. 5)
suggests that the Sim1+ cells observed in the induced culture
are not hypothalamic in nature.
One caveat worth noting is that qRT-PCR experiments
report population averaged data. Fold changes of mRNA
expression levels are reflective of an average value across
the whole experimental population in comparison to a
control population. A large increase in expression level in
qRT-PCR could represent a large increase in a few cells or a
small increase in many cells. While we see a decrease in
RAX expression across the whole population, the existence
of a rare RAX+ cell cannot be ruled out. Unfortunately, a
reliable antibody for RAX does not exist and thus pop-
ulation averaged experiments are the most direct way to
quantify the extent of RAX expression.
This study establishes a novel induction protocol for in-
ducing V3 INs from mouse ESCs by demonstrating suc-
cessful differentiation of Sim1+, nonhypothalamic cells in
cultures that also express the p3 progenitor marker Nkx2.2.
A scarce population of V3 INs exists in the developing
spinal cord, totaling *10% of the four ventral spinal cell
types, making dissection tedious and expensive. The dura-
tion and potentially scalable nature of this protocol make
our method an easier, cheaper, and faster way to obtain V3
INs than dissection. Based on the Uncx and Sim1 staining,
about 8% of the induced cells are V3 INs.
One 100mm Petri-dish of induced 2-/6+ EBs has about 21
million cells. This means about 1.6 million V3 INs can be
obtained from one induction culture on this small bench scale,
which would generally be sufficient for a rodent transplanta-
tion study. This work paves the way for future transgenic
drug-selectable or lineage tracing cell lines to better under-
stand the role of V3 INs in the spinal cord. Additionally, this
protocol for V3 IN induction could potentially be adapted for
human ESCs or induced pluripotent stem cells, much as the
MN differentiation protocols from mouse ESCs have been
adapted for these human cell types [34,35]. This method to
generate Sim1+ cells can serve as a cell source for future
studies exploring the role of V3 INs in CPGs and SCI therapy.
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